Literature DB >> 3037106

Cells expressing herpes simplex virus glycoprotein gC but not gB, gD, or gE are recognized by murine virus-specific cytotoxic T lymphocytes.

K L Rosenthal, J R Smiley, S South, D C Johnson.   

Abstract

To determine which viral molecule(s) is recognized by herpes simplex virus (HSV)-specific cytotoxic T lymphocytes (CTL), target cells were constructed which express individual HSV glycoproteins. A mouse L cell line, Z4/6, which constitutively expressed high levels of HSV type 2 (HSV-2) gD (gD-2) was isolated and characterized previously (D. C. Johnson and J. R. Smiley, J. Virol. 54:682-689, 1985). Despite the expression of gD on the surface of Z4/6 cells, these cells were not killed by anti-HSV-2 CTL generated following intravaginal infection of syngeneic mice. In contrast, parental Z4 or Z4/6 cells infected with HSV-2 were lysed. Furthermore, unlabeled Z4/6 cells were unable to block the lysis of HSV-2-infected labeled target cells. Cells which express HSV-1 gB (gB-1) were isolated by transfecting L cells with the recombinant plasmid pSV2gBneo, which contains the HSV-1 gB structural sequences and the neomycin resistance gene coupled to the simian virus 40 early promoter and selecting G418-resistant cell lines. One such cell line, Lta/gB15, expressed gB which was detected by immunoprecipitation and at the cell surface by immunofluorescence. Additionally, cells expressing HSV-1 gC (gC-1) or gE (gE-1) were isolated by transfecting Z4 cells, which are L cells expressing ICP4 and ICP47, with either the recombinant plasmid pGE15neo, which contains the gE structural sequences and the neomycin resistance gene, or pDC17, which contains the gC structural gene coupled to the gD-1 promoter. A number of G418-resistant cell lines were isolated which expressed gC-1 or gE-1 at the cell surface. Anti-HSV-1 CTL generated following footpad infection of syngeneic mice were unable to lyse target cells expressing gB-1 or gE-1. In contrast, target cells expressing very low levels of gC-1 were killed as well as HSV-1-infected target cells. Furthermore, infection of gC-1-transformed target cells with wild-type HSV-1 or a strain of HSV-1 that does not express gC did not result in a marked increase in susceptibility to lysis. These results suggest that murine class I major histocompatibility complex-restricted anti-HSV CTL recognize gC-1 but do not recognize gB, gD, or gE as these molecules are expressed in transfected syngeneic target cells. The results are discussed in terms of recent evidence concerning the specificity of antiviral CTL.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3037106      PMCID: PMC255665          DOI: 10.1128/JVI.61.8.2438-2447.1987

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Sequence determination and genetic content of the short unique region in the genome of herpes simplex virus type 1.

Authors:  D J McGeoch; A Dolan; S Donald; F J Rixon
Journal:  J Mol Biol       Date:  1985-01-05       Impact factor: 5.469

2.  Cells that constitutively express the herpes simplex virus immediate-early protein ICP4 allow efficient activation of viral delayed-early genes in trans.

Authors:  R H Persson; S Bacchetti; J R Smiley
Journal:  J Virol       Date:  1985-05       Impact factor: 5.103

3.  Herpes simplex virus type 1 glycoprotein C-negative mutants exhibit multiple phenotypes, including secretion of truncated glycoproteins.

Authors:  T C Holland; F L Homa; S D Marlin; M Levine; J Glorioso
Journal:  J Virol       Date:  1984-11       Impact factor: 5.103

4.  Characterisation and physical mapping of an HSV-1 glycoprotein of approximately 115 X 10(3) molecular weight.

Authors:  E A Buckmaster; U Gompels; A Minson
Journal:  Virology       Date:  1984-12       Impact factor: 3.616

5.  Intracellular transport of herpes simplex virus gD occurs more rapidly in uninfected cells than in infected cells.

Authors:  D C Johnson; J R Smiley
Journal:  J Virol       Date:  1985-06       Impact factor: 5.103

6.  Identification of herpes simplex virus type 1 (HSV-1) glycoprotein gC as the immunodominant antigen for HSV-1-specific memory cytotoxic T lymphocytes.

Authors:  J Glorioso; U Kees; G Kümel; H Kirchner; P H Krammer
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

7.  Human T-lymphocyte response in vitro to synthetic peptides of herpes simplex virus glycoprotein D.

Authors:  E C DeFreitas; B Dietzschold; H Koprowski
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

8.  Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells.

Authors:  A R Townsend; A J McMichael; N P Carter; J A Huddleston; G G Brownlee
Journal:  Cell       Date:  1984-11       Impact factor: 41.582

9.  Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes.

Authors:  J W Yewdell; J R Bennink; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

10.  Cell-mediated immunity to herpes simplex virus: recognition of type-specific and type-common surface antigens by cytotoxic T cell populations.

Authors:  R Eberle; R G Russell; B T Rouse
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

View more
  30 in total

1.  Identification of an immunodominant cytotoxic T-lymphocyte recognition site in glycoprotein B of herpes simplex virus by using recombinant adenovirus vectors and synthetic peptides.

Authors:  T Hanke; F L Graham; K L Rosenthal; D C Johnson
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

2.  Characterization of the antigenic structure of herpes simplex virus type 1 glycoprotein C through DNA sequence analysis of monoclonal antibody-resistant mutants.

Authors:  C T Wu; M Levine; F Homa; S L Highlander; J C Glorioso
Journal:  J Virol       Date:  1990-02       Impact factor: 5.103

3.  Application of a transformed cell line constitutively expressing HSV-1 polypeptides for the detection of HSV antibodies in human sera by an enzyme immunoassay.

Authors:  A Sivropoulou; A Vasilaki; M Arsenakis
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

4.  The herpes simplex virus UL20 protein compensates for the differential disruption of exocytosis of virions and viral membrane glycoproteins associated with fragmentation of the Golgi apparatus.

Authors:  E Avitabile; P L Ward; C Di Lazzaro; M R Torrisi; B Roizman; G Campadelli-Fiume
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

Review 5.  Glycoprotein E of pseudorabies virus and homologous proteins in other alphaherpesvirinae.

Authors:  L Jacobs
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Identification and characterization of the feline herpesvirus type 1 glycoprotein C gene.

Authors:  K Maeda; N Yokoyama; K Fujita; T Mikami
Journal:  Virus Genes       Date:  1997       Impact factor: 2.332

7.  Expression in recombinant vaccinia virus of the equine herpesvirus 1 gene encoding glycoprotein gp13 and protection of immunized animals.

Authors:  P X Guo; S Goebel; S Davis; M E Perkus; B Languet; P Desmettre; G Allen; E Paoletti
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

8.  Constitutively expressing cell lines that secrete a truncated bovine herpes virus-1 glycoprotein (gpI) stimulate T-lymphocyte responsiveness.

Authors:  T P Leary; Y Gao; G A Splitter
Journal:  Immunology       Date:  1992-07       Impact factor: 7.397

9.  Molecular characterization of naturally occurring glycoprotein C-negative herpes simplex virus type 1.

Authors:  Y Toh; S Tanaka; Y Liu; Y Hidaka; R Mori
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Construction and properties of a mutant of herpes simplex virus type 1 with glycoprotein H coding sequences deleted.

Authors:  A Forrester; H Farrell; G Wilkinson; J Kaye; N Davis-Poynter; T Minson
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.